This study seeks to determine the clinical characteristics of young ESUS patients using diagnostic criteria of the Cryptogenic Stroke / ESUS International Working Group, and to determine the rates of stroke recurrence, death, and hospital readmission in a contemporary cohort of young ESUS patients during follow-up of up to 18 months.
Patients presenting to hospital-based stroke unit with an ESUS Stroke
|Type||Measure||Time Frame||Safety Issue|
|Primary||Recurrent ischemic stroke and/or death in a well-defined Young ESUS cohort||Approximately 18 Months|
|Secondary||Recurrent ischemic stroke in a well-defined Young ESUS cohort||Approximately 18 Months|
|Secondary||Prevalence of Patent Foramen Ovale in a well-defined Young ESUS cohort||Baseline|